Microparticles reveal cell activation during IVF - a possible early marker of a prothrombotic state during the first

Nina Olausson1, Fariborz Mobarrez, Håkan Wallen

  • 1Nina Olausson, Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, SE 18288 Stockholm, Sweden, Tel.: +46 7 052 302 20, Fax: +46 8 123 571 17,

Insights

In vitro fertilization (IVF) ovarian stimulation significantly increases cell-derived microparticles (MPs) and activation markers. These changes, linked to elevated estrogen, may contribute to the increased risk of venous thromboembolism (VTE) in IVF pregnancies.

Area of Science:

  • Reproductive Medicine
  • Hematology
  • Cell Biology

Background:

  • Cell-derived microparticles (MPs) are implicated in arterial and venous thromboembolism (VTE).
  • IVF-associated pregnancies carry an increased risk of VTE, with underlying mechanisms poorly understood.
  • Ovarian stimulation during IVF involves significant hormonal fluctuations, particularly estrogen.

Purpose of the Study:

  • To investigate cell activation during IVF by analyzing microparticle (MP) levels and phenotypes.
  • To assess the impact of ovarian stimulation on circulating MPs and cell activation markers.

Main Methods:

  • Flow cytometry was used to analyze and phenotype MPs from 31 women undergoing IVF.
  • Blood samples were collected during estrogen downregulation and high-level stimulation phases.
  • Analysis focused on phosphatidylserine-positive MPs, platelet activation markers (CD40 ligand, P-selectin), and endothelial activation markers (E-selectin).

Main Results:

  • A significant increase in platelet-, endothelial-, and monocyte-derived MPs was observed post-ovarian stimulation.
  • Elevated levels of platelet activation markers (CD40 ligand, P-selectin) and endothelial activation marker E-selectin were noted.
  • Neutrophil-derived MPs showed a slight decrease, while monocyte-derived MPs increased.

Conclusions:

  • IVF ovarian stimulation leads to a substantial increase in MPs and cell activation markers, correlating with high estrogen levels.
  • These findings suggest a potential link between IVF-induced hormonal changes and prothrombotic states.
  • Further longitudinal studies are required to determine if these MP changes are associated with actual thromboembolic events.

Related Concept Videos

In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
1.3K
Fertilization01:38

Fertilization

During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...
93.6K
Meiosis II01:57

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
210.0K